Papers

Peer-reviewed International journal
Apr, 2021

Antagonism for NPY signaling reverses cognitive behavior defects induced by activity-based anorexia in mice.

Psychoneuroendocrinology
  • Natasya Trivena Rokot
  • ,
  • Koji Ataka
  • ,
  • Haruki Iwai
  • ,
  • Hajime Suzuki
  • ,
  • Homare Tachibe
  • ,
  • Timothy Sean Kairupan
  • ,
  • Kai-Chun Cheng
  • ,
  • Haruka Amitani
  • ,
  • Akio Inui
  • ,
  • Akihiro Asakawa

Volume
126
Number
First page
105133
Last page
105133
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1016/j.psyneuen.2021.105133

Patients with AN often express psychological symptoms such as body image distortion, cognitive biases, abnormal facial recognition, and deficits in working memory. However, the molecular mechanisms underlying the impairment of cognitive behaviors in AN remain unknown. In the present study, we measured cognitive behavior using novel object recognition (NOR) tasks and mRNA expressions in hypothalamic neuropeptides in female C57BL/6J mice with activity-based anorexia (ABA). Additionally, we evaluated the effects of antagonists with intracerebroventricular (icv) administration on the impairment of cognitive behavior in NOR tasks. Our results showed that NOR indices were lowered, subsequently increasing mRNA levels of agouti-related peptide (AgRP) and neuropeptide Y (NPY), and c-Fos- and AgRP- or NPY-positive cells in the hypothalamic arcuate nucleus in ABA mice. We also observed that icv administration of anti-NPY antiserum (2 µl), anti-AgRP antibody (0.1 μg), and Y5 receptor antagonist CPG71683 (15 nmol) significantly reversed the decreased NOR indices. Therefore, our results suggest that increased NPY and AgRP signaling in the brain might contribute to the impairment of cognitive behavior in AN.

Link information
DOI
https://doi.org/10.1016/j.psyneuen.2021.105133
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33540372
ID information
  • DOI : 10.1016/j.psyneuen.2021.105133
  • Pubmed ID : 33540372

Export
BibTeX RIS